Filtered By:
Management: Food and Drug Administration (FDA)
This page shows you your search results in order of date. This is page number 9.
Order by Relevance | Date
Total 1725 results found since Jan 2013.
When Adolescents Disagree with Their Vaccine-Hesitant Parents about COVID-19 Vaccination
This article discusses parental vaccine hesitancy and argues that permitting independent adolescent consent to COVID-19 vaccination should be an ethical and policy priority as we continue to confront the threat of Omicron and other variants of the coronavirus. We discuss the central role of the pediatric healthcare team in caring for adolescent patients who disagree with their parents about vaccination.PMID:37229735 | DOI:10.1086/724746
Source: Journal of Clinical Ethics - May 25, 2023 Category: Medical Ethics Authors: Robert S Olick Y Tony Yang Jana Shaw Source Type: research
Neutralizing antibodies against omicron BA.5 among children with infection alone, vaccination alone, and hybrid immunity
Children with severe acute respiratory coronavirus 2 (SARS-CoV-2) infection commonly present with mild symptoms and a trend of lesser disease severity compared to adults. However, a higher risk of severe COVID-19 disease has been found in children with underlying diseases [1]. Although the U.S. Food and Drug Administration authorized mRNA COVID-19 vaccines for children aged 5-11 years old by October 2021, more than half of children have been infected due to the spread of highly transmissible variants, such as omicron [2].
Source: International Journal of Infectious Diseases - May 17, 2023 Category: Infectious Diseases Authors: Nungruthai Suntronwong, Sitthichai Kanokudom, Suvichada Assawakosri, Preeyaporn Vichaiwattana, Sirapa Klinfueng, Harit Phowatthanasathian, Jira Chansaenroj, Donchida Srimuan, Thaksaporn Thatsanathorn, Thaneeya Duangchinda, Warangkana Chantima, Pattarakul Tags: Short Communication Source Type: research
F.D.A. Eases Ban on Blood Donations From Gay and Bisexual Men
But men who had multiple sex partners or were taking PrEP medications in the last three months would still be barred from donating blood.
Source: NYT Health - May 11, 2023 Category: Consumer Health News Authors: Christina Jewett Tags: Homosexuality and Bisexuality Blood Discrimination Blood Donation Acquired Immune Deficiency Syndrome Transfusions Shortages Coronavirus (2019-nCoV) Food and Drug Administration Gay and Lesbian Alliance Against Defamation Source Type: news
The use of remdesivir in patients with COVID-19
Infect Disord Drug Targets. 2023 May 9. doi: 10.2174/1871526523666230509110907. Online ahead of print.ABSTRACTRemdesivir has appeared to be the most effective medication against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and is broadly administered to coronavirus disease 2019 (COVID-19) patients around the world. Remdesivir is an RNA polymerase inhibitor with a broad spectrum of antiviral activities against RNA viruses in in-vitro and in-vivo models of SARS-CoV, the Middle East respiratory syndrome (MERS), and SARS-CoV-2. Remdesivir is the first Food and Drug Administration (FDA) approved an...
Source: Infectious Disorders Drug Targets - May 11, 2023 Category: Infectious Diseases Authors: Zeinab Mohseni Afshar Dariush Hosseinzadeh Rezvan Hosseinzadeh Arefeh Babazadeh Amirreza Allahgholipour Terence T Sio Mark J M Sullman Kristin Carson-Chahhoud Mohammad Barary Soheil Ebrahimpour Source Type: research
Why It Took So Long to Finally Get an RSV Vaccine
Respiratory syncytial virus (RSV) can dangerously compromise breathing, especially for infants and the elderly. But there has been no vaccine to prevent it—until today. On May 3, the U.S. Food and Drug Administration (FDA) approved the first vaccine against RSV, from GlaxoSmithKline (GSK), to prevent respiratory disease in people ages 60 and older. The Centers for Disease Control’s vaccine committee will make formal recommendations in June about who should receive the vaccine, but GSK says it currently has enough doses to vaccinate eligible people beginning this fall.
In studies involving 25,000 people that GSK...
Source: TIME: Health - May 3, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Drugs healthscienceclimate Source Type: news
Neurological Considerations with COVID-19 Vaccinations
Semin Neurol DOI: 10.1055/s-0043-1767725The benefits of coronavirus disease 2019 (COVID-19) vaccination significantly outweigh its risks on a public health scale, and vaccination has been crucial in controlling the spread of SARS-CoV-2. Nonetheless, several reports of adverse events following vaccination have been published.To summarize reports to date and assess the extent and quality of evidence regarding possible serious adverse neurological events following COVID-19 vaccination, focusing on Food and Drug Administration (FDA)-approved vaccines in the United States (BNT162b2, mRNA-1273, and Ad26.COV2.S).A review of liter...
Source: Seminars in Neurology - April 24, 2023 Category: Neurology Authors: Boruah, Abhilasha P. Heydari, Kimia Wapniarski, Anne E. Caldwell, Marissa Thakur, Kiran T. Tags: Review Article Source Type: research
FDA Authorizes Another Covid Booster Shot for People Over 65
Seniors and people with compromised immune systems may get a second bivalent booster if at least four months have passed since their last one.
Source: NYT Health - April 18, 2023 Category: Consumer Health News Authors: Christina Jewett Tags: Coronavirus (2019-nCoV) Vaccination and Immunization Coronavirus Omicron Variant Food and Drug Administration your-feed-healthcare Source Type: news
FDA Clears Second Bivalent COVID-19 Booster for People 65 and Older
WASHINGTON — U.S. regulators on Tuesday cleared another COVID-19 booster dose for older adults and people with weak immune systems so they can shore up protection this spring — while taking steps to make coronavirus vaccinations simpler for everyone else.
The Food and Drug Administration said anyone 65 or older can opt to roll up their sleeves again as long as it’s been at least four months since their first dose of the so-called bivalent vaccine that targets Omicron strains.
And most people who are immune-compromised can choose another bivalent booster shot at least two months later, with additional dose...
Source: TIME: Health - April 18, 2023 Category: Consumer Health News Authors: Lauran Neergaard/AP Tags: Uncategorized COVID-19 healthscienceclimate wire Source Type: news
News at a glance: New U.S. coronavirus research, lab gear ’s carbon cost, and a repurposed accelerator
MATERIALS SCIENCE
Storied accelerator to test chips
The world’s first superconducting cyclotron will receive a new lease on life testing next-generation microchips, Michigan State University’s Facility for Rare Isotope Beams (FRIB) announced last week. From 1982 to 2020, the K-500 cyclotron produced beams of atomic nuclei ranging from hydrogen to uranium for experiments in nuclear physics, relying on superconducting magnets to confine the particles. Last year, the cyclotron was replaced by FRIB’s new, more powerful, $730 million linear accelerator. Typically, old particle accelerators are demolished or...
Source: Science of Aging Knowledge Environment - April 13, 2023 Category: Geriatrics Source Type: research
FDA to Allow a Second Updated Covid Booster for Seniors and the Immunocompromised
Federal regulators plan to authorize an additional dose for seniors and immunocompromised people in the coming weeks, ahead of the introduction of a newly formulated booster later in the year.
Source: NYT Health - April 4, 2023 Category: Consumer Health News Authors: Noah Weiland and Sharon LaFraniere Tags: Coronavirus (2019-nCoV) Vaccination and Immunization Food and Drug Administration Immune System Elderly United States Politics and Government Source Type: news
An Oura Ring Could Detect COVID-19 Days Before Symptoms Appear
Nobody wants to get sick, but knowing you’ll soon be battling a virus could, at the very least, help you prepare for what’s coming.
Such knowledge could be particularly useful when it comes to COVID-19. Granted, the symptoms of the latest Omicron variants don’t tend to be severe, but testing positive means isolating for several days so you don’t pass the virus on to others. Knowing you’re infected could help more people take this step and potentially slow the spread of disease.
In a study published on March 29 in Digital Biomarkers, researchers at Oura—which makes a smart ring that track...
Source: TIME: Health - March 29, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Should You Get Another Covid Booster?
Britain and Canada have authorized another round of booster shots for older and immunocompromised citizens. So far, U.S. officials haven ’t followed suit.
Source: NYT Health - March 24, 2023 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: your-feed-science Coronavirus (2019-nCoV) Vaccination and Immunization Elderly Immune System Food and Drug Administration Source Type: news
